Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 23, 2015, 35 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $6.95 to $40,848,330.25.

Highlighted Stocks Traded by Insiders:

State Auto Financial (STFC) - FREE Research Report

State Automobile Mutual Insurance Co, who is 10% Owner at State Auto Financial, bought 3,216 shares at $23.84 on April 23, 2015. Following this transaction, the 10% Owner owned 25.8 million shares meaning that the stake was boosted by 0.01% with the 3,216-share transaction.

The shares most recently traded at $23.95, up $0.11, or 0.45% since the insider transaction. Historical insider transactions for State Auto Financial go as follows:

  • 4-Week # shares bought: 74,465
  • 12-Week # shares bought: 174,887
  • 24-Week # shares bought: 267,191

The average volume for State Auto Financial has been 35,100 shares per day over the past 30 days. State Auto Financial has a market cap of $979.7 million and is part of the financial sector and insurance industry. Shares are up 7.25% year-to-date as of the close of trading on Thursday.

State Auto Financial Corporation, through its subsidiaries, engages in writing personal, business, and specialty insurance products. It operates through four segments: Personal insurance, Business insurance, Specialty insurance, and Investment operations. The stock currently has a dividend yield of 1.68%. The company has a P/E ratio of 9.2. Currently, there is 1 analyst who rates State Auto Financial a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on STFC - FREE

TheStreet Quant Ratings rates State Auto Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full State Auto Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AcelRx Pharmaceuticals (ACRX) - FREE Research Report

Afable Richard, who is Director at AcelRx Pharmaceuticals, bought 1,000 shares at $10.30 on April 23, 2015. Following this transaction, the Director owned 1,000 shares meaning that the stake was boosted by 100% with the 1,000-share transaction.

The shares most recently traded at $4.79, down $5.51, or 115.03% since the insider transaction. Historical insider transactions for AcelRx Pharmaceuticals go as follows:

  • 24-Week # shares bought: 10,000

The average volume for AcelRx Pharmaceuticals has been 685,700 shares per day over the past 30 days. AcelRx Pharmaceuticals has a market cap of $196.7 million and is part of the health care sector and health services industry. Shares are down 33.14% year-to-date as of the close of trading on Thursday.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. Currently, there is 1 analyst who rates AcelRx Pharmaceuticals a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACRX - FREE

TheStreet Quant Ratings rates AcelRx Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full AcelRx Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Computer (CSC) - FREE Research Report

Lawrie John M, who is President and CEO at Computer, sold 8,000 shares at $65.35 on April 23, 2015. Following this transaction, the President and CEO owned 86,481 shares meaning that the stake was reduced by 8.47% with the 8,000-share transaction.

The shares most recently traded at $65.42, up $0.07, or 0.11% since the insider transaction. Historical insider transactions for Computer go as follows:

  • 4-Week # shares sold: 8,000
  • 12-Week # shares sold: 55,700
  • 24-Week # shares sold: 148,000

The average volume for Computer has been 1.6 million shares per day over the past 30 days. Computer has a market cap of $9.3 billion and is part of the technology sector and computer software & services industry. Shares are up 4.41% year-to-date as of the close of trading on Thursday.

Computer Sciences Corporation provides information technology (IT) and professional services and solutions in North America, Europe, Asia, and Australia. The company operates through Global Business Services, Global Infrastructure Services, and North American Public Sector segments. The stock currently has a dividend yield of 1.4%. The company has a P/E ratio of 313.5. Currently, there are 2 analysts who rate Computer a buy, 2 analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSC - FREE

TheStreet Quant Ratings rates Computer as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Computer Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null